Last update 26 Apr 2025

DNX-514

Overview

Basic Info

Drug Type
Single-chain FV antibody fragment
Synonyms
DNX-514
Target
TNF
Action
inhibitors
Mechanism
TNF inhibitors(Tumor necrosis factor inhibitors)
Therapeutic Areas
Immune System DiseasesInfectious DiseasesDigestive System Disorders+ [2]
Active Indication-
Inactive Indication
Ankylosing SpondylitisArthritis, PsoriaticColitis, Ulcerative+ [4]
Originator Organization
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
Active Organization-
Inactive Organization
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with DNX-514
Login to view more data
100 Translational Medicine associated with DNX-514
Login to view more data
100 Patents (Medical) associated with DNX-514
Login to view more data
100 Deals associated with DNX-514
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Ankylosing SpondylitisPreclinical
United States
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
31 Aug 2022
Arthritis, PsoriaticPreclinical
United States
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
31 Aug 2022
Colitis, UlcerativePreclinical
United States
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
31 Aug 2022
Crohn DiseasePreclinical
United States
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
31 Aug 2022
Juvenile Idiopathic ArthritisPreclinical
United States
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
31 Aug 2022
Plaque psoriasisPreclinical
United States
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
31 Aug 2022
Rheumatoid ArthritisPreclinical
United States
DNX Biopharmaceuticals, Inc.DNX Biopharmaceuticals, Inc.Startup
31 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free